全文获取类型
收费全文 | 1593篇 |
免费 | 40篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 30篇 |
妇产科学 | 16篇 |
基础医学 | 535篇 |
口腔科学 | 17篇 |
临床医学 | 173篇 |
内科学 | 165篇 |
皮肤病学 | 16篇 |
神经病学 | 48篇 |
特种医学 | 51篇 |
外科学 | 82篇 |
综合类 | 40篇 |
预防医学 | 159篇 |
眼科学 | 16篇 |
药学 | 176篇 |
中国医学 | 4篇 |
肿瘤学 | 88篇 |
出版年
2022年 | 17篇 |
2021年 | 16篇 |
2019年 | 18篇 |
2018年 | 17篇 |
2016年 | 23篇 |
2015年 | 24篇 |
2014年 | 24篇 |
2013年 | 23篇 |
2012年 | 42篇 |
2011年 | 47篇 |
2010年 | 45篇 |
2009年 | 28篇 |
2008年 | 32篇 |
2007年 | 49篇 |
2006年 | 64篇 |
2005年 | 41篇 |
2004年 | 39篇 |
2003年 | 34篇 |
2002年 | 54篇 |
2001年 | 57篇 |
2000年 | 40篇 |
1999年 | 40篇 |
1998年 | 23篇 |
1997年 | 18篇 |
1996年 | 22篇 |
1995年 | 21篇 |
1994年 | 18篇 |
1992年 | 34篇 |
1991年 | 48篇 |
1990年 | 50篇 |
1989年 | 46篇 |
1988年 | 41篇 |
1987年 | 34篇 |
1986年 | 34篇 |
1985年 | 36篇 |
1984年 | 33篇 |
1983年 | 29篇 |
1982年 | 16篇 |
1980年 | 15篇 |
1979年 | 23篇 |
1978年 | 19篇 |
1977年 | 17篇 |
1976年 | 27篇 |
1975年 | 23篇 |
1974年 | 25篇 |
1972年 | 22篇 |
1971年 | 23篇 |
1969年 | 20篇 |
1966年 | 16篇 |
1965年 | 14篇 |
排序方式: 共有1634条查询结果,搜索用时 15 毫秒
31.
Two-hundred and eighty bacterial isolates from wound and soft tissue infections were studied for species identification and antibiotic resistance pattern. Amongst them 122 isolates were from community acquired infection and 158 were from nosocomial infections. The common community acquired pathogens were Staphylococcus aureus (67.8%) and Streptococcus pyogenes (10.7%), whereas Staphylococcus aureus (60.1%) and E. Coli (8.9%) were common in nosocomial infection. Only two anaerobes (Cl perfringens) were isolated. Penicillin resistance was found to be 87% and 92% for Staphylococccus aureus in community acquired and noscomial infections respectively. 85% of Proteus isolates were resistant to ampicillin. There was relatively lower level of resistance by all isolates to cefotaxime. Gentamicin showed higher rate of resistance than netilmicin and amikacin. Resistance of E. coli isolates to fluoroquinolones being 79% for norfloxacin, 81% for ciprofloxacin and 60% for ofloxacin. The study showed a higher resistance of methicillin resistant Staphylococcus aureus (MRSA) to other antibiotics. Amikacin and ofloxacin were the best recommended drugs for empirical therapy for all organisms, the susceptibility rate being 80.7% and 80.4%.KEY WORDS: Antibiotic resistance, Soft tissue infections, Wound infections 相似文献
32.
33.
34.
35.
A. V. Popova V. P. Myakinina M. E. Platonov N. V. Volozhantsev 《Molecular Genetics, Microbiology and Virology》2012,27(4):154-159
Molecular genetic analysis of 130 multidrug-resistant nosocomial Acinetobacter baumannii strains was performed. The strains were obtained from patients admitted to different hospitals in large Russian cities (Chelyabinsk, Moscow, Nizhny Novgorod, and St. Petersburg) in 2005–2010. Species identification was performed by the amplified 16S rRNA gene restriction analysis and by determining the bla OXA-51-like genes intrinsic for A. baumannii using PCR. Genetic typing of the strains was performed by RAPD-PCR. All strains fell into two clusters, A and B, with the dominant RAPD groups A1 and B1, respectively, including 82% (107 out of 130) of all strains under study. Susceptibility of the strains to bacteriophage AP22 was determined. The phage was shown to infect specifically and to lyse 69% of 130 strains and 82% (88 out of 107) of A. baumannii strains from the dominant RAPD groups. The ability of bacteriophage AP22 to lyse a broad range of clinically relevant A. baumannii strains makes it an attractive candidate for designing phage cocktails intended to control the A. baumannii-associated nosocomial infections. Moreover, the phage can be used for identifying A. baumannii in the bacteriological tests of clinical samples. 相似文献
36.
37.
38.
Hasegawa DK; Bennett AJ; Coccia PF; Ramsay NK; Nesbit ME; Krivit W; Edson JR 《Blood》1980,56(4):585-595
Factor V deficiency has been identified in 8 of 8 patients 7--20 yr of age, with Philadelphia-positive (Ph1+) chronic myelogenous leukemia (CML). In these 8 patients, factor V deficiency was not due to hepatic dysfunction, factor V inhibitors, or disseminated intravascular coagulation. In 3 patients, factor V activity rose 10%--12% (0.10--0.12 U/ml) after the infusion of 28--31 ml/kg body weight of fresh frozen plasma (FFP). The rise persisted less than 14 hr. The mean measured postinfusion rise in factor V was 18% of the expected rise calculated from the volume of FFP infused in the patients' plasma volume. In 4 patients, a small transient rise in factor V activity occurred after splenectomy or plateletpheresis. Factor V deficiency was completely corrected after a marked reduction in bone marrow cellularity in 2 patients with Ph1+ CML treated with extensive chemotherapy, total body irradiation, and bone marrow transplantation. Factor V deficiency was retrospectively observed in 6 of 20 patients, ages 20--80 yr, with Ph1+ CML and 3 of 6 patients with other myeloproliferative disorders. The factor V deficiency appears to be associated with the large myeloid- megakaryocytic cell mass characteristic of CML and other myeloproliferative disorders. 相似文献
39.
Sushma Bhatnagar Saraswathi Devi NK Vinod PN Jain G Durgaprasad Sanjaykumar H Maroo Ketan R Patel 《Indian Journal of Palliative Care》2014,20(3):182-187
Aim:
To compare the efficacy and safety of oral transmucosal fentanyl citrate (OTFC) and oral morphine in Indian patients with breakthrough episodes of cancer pain.Materials and Methods:
In this randomized, open label, active controlled, clinical study, total 186 patients who regularly experienced 1-4 episodes of breakthrough cancer pain (BTCP) daily, over the persistent pain controlled by taking oral morphine 60 mg/day or its equivalent were randomized to receive either OTFC 200 mcg or oral morphine 10 mg for the treatment of BTCP for 3 days. Improvement in pain as determined by numerical rating scale (NRS) at 5, 15, 30, and 60 minutes of drug administration and percentage of BTCP episodes showing reduction in pain intensity by >33% at 15 minutes were primary efficacy endpoints. Secondary efficacy endpoints were requirement for rescue analgesia and global assessment by physician and patient. Data of both treatment groups were analysed by appropriate statistical test using software, STATISTICA, version 11.Results:
Patients treated with OTFC experienced significantly greater improvement in pain intensity of breakthrough episodes compared to those treated with oral morphine at all assessment time points (P < 0.0001). 56% of breakthrough pain episodes treated with OTFC showed a greater than 33% reduction in pain intensity from baseline at 15 minutes compared to 39% episodes treated with oral morphine (P < 0.0001). Patient''s and physician''s global assessment favoured OTFC than oral morphine (P < 0.0001). Requirement of rescue analgesia in both the study groups was similar (P > 0.05). Both study drugs were well tolerated.Conclusions:
OTFC was found to provide faster onset of analgesic effect than immediate release oral morphine in management of breakthrough cancer pain. 相似文献40.
Popova O. A. Bunyatyan N. D. Bobizoda G. M. Samiev M. Prokof’ev A. B. Evteev V. A. Sernov L. N. 《Pharmaceutical Chemistry Journal》2020,54(9):914-917
Pharmaceutical Chemistry Journal - Tripeptide H-Lys-Lys-Gly-OH was synthesized. Its toxic properties and biological activity were studied. The tripeptide was synthesized by extending the peptide... 相似文献